| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 2.35e-05 | 14 | 82 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.65e-04 | 5 | 82 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | RNA polymerase III type 3 promoter sequence-specific DNA binding | 2.47e-04 | 6 | 82 | 2 | GO:0001006 | |
| GeneOntologyMolecularFunction | RNA polymerase III cis-regulatory region sequence-specific DNA binding | 3.45e-04 | 7 | 82 | 2 | GO:0000992 | |
| GeneOntologyMolecularFunction | RNA polymerase III transcription regulatory region sequence-specific DNA binding | 4.59e-04 | 8 | 82 | 2 | GO:0001016 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 8.92e-04 | 46 | 82 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | poly(A) RNA polymerase activity | 1.07e-03 | 12 | 82 | 2 | GO:1990817 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.48e-05 | 46 | 84 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | endosome | MRC1 AP3S1 CLTCL1 WASHC4 ZMPSTE24 MYO1D SBF2 TBCK CD164 ZFYVE26 FYCO1 TLR7 ACKR2 SLC9A6 TRAPPC1 | 5.71e-05 | 1167 | 84 | 15 | GO:0005768 |
| GeneOntologyCellularComponent | early endosome | AP3S1 CLTCL1 WASHC4 ZMPSTE24 MYO1D TBCK ZFYVE26 ACKR2 SLC9A6 | 1.34e-04 | 481 | 84 | 9 | GO:0005769 |
| GeneOntologyCellularComponent | calcium channel complex | 2.14e-04 | 73 | 84 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | T-tubule | 2.90e-04 | 79 | 84 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 1.03e-03 | 12 | 84 | 2 | GO:1990454 | |
| Domain | CAC1F_C | 7.86e-08 | 3 | 81 | 3 | IPR031688 | |
| Domain | CAC1F_C | 7.86e-08 | 3 | 81 | 3 | PF16885 | |
| Domain | VDCC_L_a1su | 3.13e-07 | 4 | 81 | 3 | IPR005446 | |
| Domain | VDCC_a1su_IQ | 2.72e-06 | 7 | 81 | 3 | IPR014873 | |
| Domain | GPHH | 2.72e-06 | 7 | 81 | 3 | PF16905 | |
| Domain | GPHH_dom | 2.72e-06 | 7 | 81 | 3 | IPR031649 | |
| Domain | Ca_chan_IQ | 2.72e-06 | 7 | 81 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 2.72e-06 | 7 | 81 | 3 | PF08763 | |
| Domain | VDCCAlpha1 | 9.23e-06 | 10 | 81 | 3 | IPR002077 | |
| Domain | - | 5.56e-05 | 3 | 81 | 2 | 3.30.70.590 | |
| Domain | PAP_central | 5.56e-05 | 3 | 81 | 2 | PF04928 | |
| Domain | PAP_RNA-bind | 5.56e-05 | 3 | 81 | 2 | PF04926 | |
| Domain | PolA_pol_cen_dom | 5.56e-05 | 3 | 81 | 2 | IPR007012 | |
| Domain | PolA_pol_RNA-bd_dom | 5.56e-05 | 3 | 81 | 2 | IPR007010 | |
| Domain | PolyA_polymerase | 5.56e-05 | 3 | 81 | 2 | IPR014492 | |
| Domain | NuclTrfase_I_C | 5.56e-05 | 3 | 81 | 2 | IPR011068 | |
| Domain | NTP_transf_2 | 9.96e-04 | 11 | 81 | 2 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 9.96e-04 | 11 | 81 | 2 | IPR002934 | |
| Domain | P_typ_ATPase_c | 1.63e-03 | 14 | 81 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 1.63e-03 | 14 | 81 | 2 | IPR032631 | |
| Domain | ATPase_dyneun-rel_AAA | 1.63e-03 | 14 | 81 | 2 | IPR011704 | |
| Domain | P-type_ATPase_IV | 1.63e-03 | 14 | 81 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 1.63e-03 | 14 | 81 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 1.63e-03 | 14 | 81 | 2 | PF16209 | |
| Domain | AAA_5 | 1.63e-03 | 14 | 81 | 2 | PF07728 | |
| Domain | Channel_four-helix_dom | 1.94e-03 | 57 | 81 | 3 | IPR027359 | |
| Domain | - | 1.94e-03 | 57 | 81 | 3 | 1.20.120.350 | |
| Domain | Chemokine_rcpt | 2.14e-03 | 16 | 81 | 2 | IPR000355 | |
| Domain | Longin-like_dom | 6.53e-03 | 28 | 81 | 2 | IPR011012 | |
| Domain | FYVE | 6.99e-03 | 29 | 81 | 2 | PF01363 | |
| Domain | FYVE | 6.99e-03 | 29 | 81 | 2 | SM00064 | |
| Domain | Thioredoxin | 7.96e-03 | 31 | 81 | 2 | PF00085 | |
| Domain | - | 8.47e-03 | 32 | 81 | 2 | 3.40.1110.10 | |
| Domain | LRRCT | 8.47e-03 | 32 | 81 | 2 | PF01463 | |
| Domain | - | 8.47e-03 | 32 | 81 | 2 | 2.70.150.10 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.61e-06 | 6 | 62 | 3 | M47762 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 2.85e-05 | 14 | 62 | 3 | M47692 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.35e-04 | 23 | 62 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.74e-04 | 25 | 62 | 3 | M47948 | |
| Pubmed | 5.43e-08 | 4 | 84 | 3 | 20937870 | ||
| Pubmed | 4.72e-07 | 7 | 84 | 3 | 12900400 | ||
| Pubmed | 2.21e-06 | 11 | 84 | 3 | 18809727 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 20014384 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 30653446 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 30001160 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21352396 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21054386 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 5.76e-06 | 2 | 84 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 5.76e-06 | 2 | 84 | 2 | 16267232 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24996399 | ||
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 5.76e-06 | 2 | 84 | 2 | 25966695 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24086669 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24849370 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 31120193 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24357920 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 5.76e-06 | 2 | 84 | 2 | 26049024 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 17015854 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 5.76e-06 | 2 | 84 | 2 | 16706838 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 23761887 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 14981074 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 5.76e-06 | 2 | 84 | 2 | 25292336 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 17526649 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 12606379 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 5.76e-06 | 2 | 84 | 2 | 24941892 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24848473 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22826131 | ||
| Pubmed | C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. | 5.76e-06 | 2 | 84 | 2 | 16921373 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24470632 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24760982 | ||
| Pubmed | 6.06e-06 | 15 | 84 | 3 | 20188150 | ||
| Pubmed | 6.06e-06 | 15 | 84 | 3 | 24453333 | ||
| Pubmed | 1.12e-05 | 438 | 84 | 8 | 32628020 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 19351867 | ||
| Pubmed | Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth. | 1.73e-05 | 3 | 84 | 2 | 21832054 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 17289261 | ||
| Pubmed | Potent inhibition of L-type Ca2+ currents by a Rad variant associated with congestive heart failure. | 1.73e-05 | 3 | 84 | 2 | 23973784 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 17767505 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 31302118 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 23045342 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 2173707 | ||
| Pubmed | Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. | 1.73e-05 | 3 | 84 | 2 | 24934288 | |
| Pubmed | Hypothalamic Grb10 enhances leptin signalling and promotes weight loss. | 1.73e-05 | 3 | 84 | 2 | 36593271 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 21081500 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 26831068 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 23338940 | ||
| Pubmed | Exendin-4 improves β-cell function in autophagy-deficient β-cells. | 1.73e-05 | 3 | 84 | 2 | 24105478 | |
| Pubmed | Genetic dissection of horizontal cell inhibitory signaling in mice in complete darkness in vivo. | 1.73e-05 | 3 | 84 | 2 | 26024096 | |
| Pubmed | FANCD2 TNPO1 KIFBP AP3S1 WASHC4 FBXO3 WDR75 MYO1D ATG7 MRPS17 TBCK CDC23 PTCD3 | 1.84e-05 | 1335 | 84 | 13 | 29229926 | |
| Pubmed | 2.41e-05 | 638 | 84 | 9 | 31182584 | ||
| Pubmed | 2.62e-05 | 493 | 84 | 8 | 15368895 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 25098764 | ||
| Pubmed | Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. | 3.45e-05 | 4 | 84 | 2 | 17110593 | |
| Pubmed | The AAA ATPase MDN1 Acts as a SUMO-Targeted Regulator in Mammalian Pre-ribosome Remodeling. | 3.45e-05 | 4 | 84 | 2 | 27814492 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 12880872 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 23801521 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 8491200 | ||
| Pubmed | Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504. | 3.45e-05 | 4 | 84 | 2 | 26941017 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 4.29e-05 | 262 | 84 | 6 | 36880596 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 15451373 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 31663850 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 11296258 | ||
| Pubmed | 8.37e-05 | 750 | 84 | 9 | 11230166 | ||
| Pubmed | Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse. | 8.59e-05 | 6 | 84 | 2 | 16029198 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 21224388 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 12446734 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 23734214 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.08e-04 | 38 | 84 | 3 | 30786075 | |
| Pubmed | The SUMO system controls nucleolar partitioning of a novel mammalian ribosome biogenesis complex. | 1.20e-04 | 7 | 84 | 2 | 21326211 | |
| Pubmed | CDC50 proteins are critical components of the human class-1 P4-ATPase transport machinery. | 1.20e-04 | 7 | 84 | 2 | 20961850 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 20947505 | ||
| Pubmed | Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. | 1.20e-04 | 7 | 84 | 2 | 24280982 | |
| Pubmed | Anthracyclines induce DNA damage response-mediated protection against severe sepsis. | 1.20e-04 | 7 | 84 | 2 | 24184056 | |
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 27631554 | ||
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 28330839 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 16382099 | ||
| Pubmed | Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. | 2.05e-04 | 9 | 84 | 2 | 18097414 | |
| Pubmed | 2.86e-04 | 371 | 84 | 6 | 15747579 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 3.68e-04 | 139 | 84 | 4 | 16985003 | |
| Pubmed | 3.75e-04 | 12 | 84 | 2 | 17182038 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 3.85e-04 | 552 | 84 | 7 | 10737800 | |
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 4.42e-04 | 13 | 84 | 2 | 11015572 | |
| Pubmed | 4.88e-04 | 952 | 84 | 9 | 38569033 | ||
| Pubmed | 5.15e-04 | 14 | 84 | 2 | 31857374 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 5.26e-04 | 272 | 84 | 5 | 25315684 | |
| Pubmed | Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants. | 5.93e-04 | 15 | 84 | 2 | 20970119 | |
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 9139699 | ||
| Pubmed | 6.19e-04 | 282 | 84 | 5 | 23667531 | ||
| Pubmed | Asprosin-neutralizing antibodies as a treatment for metabolic syndrome. | 6.77e-04 | 16 | 84 | 2 | 33904407 | |
| Pubmed | FANCD2 TNPO1 KIFBP AP3S1 CLTCL1 MDN1 MRPS17 TRAM1 NCLN TRAPPC1 PTCD3 | 6.85e-04 | 1440 | 84 | 11 | 30833792 | |
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 7.66e-04 | 17 | 84 | 2 | 27725084 | |
| Pubmed | 7.66e-04 | 17 | 84 | 2 | 28634350 | ||
| Pubmed | 8.60e-04 | 18 | 84 | 2 | 23085235 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNA1C LPAR3 LRRN1 ATG7 INPP5A SBF2 TUSC3 TBCK GRB10 ATP8B1 FARP2 | 9.01e-04 | 1489 | 84 | 11 | 28611215 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | FANCD2 SFXN4 KIFBP SLC4A7 MDN1 WDR75 MYO1D MRPS17 NCLN CDC23 PTCD3 | 9.36e-04 | 1496 | 84 | 11 | 32877691 |
| Pubmed | SLC4A7 MDN1 WDR75 UTP25 MRPS17 TRAM1 SENP3 ZMYM2 PREX1 PTCD3 FARP2 | 9.41e-04 | 1497 | 84 | 11 | 31527615 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 9.88e-04 | 313 | 84 | 5 | 38270169 | |
| Pubmed | A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors. | 1.06e-03 | 20 | 84 | 2 | 35224516 | |
| Pubmed | SENP3 and USP7 regulate Polycomb-rixosome interactions and silencing functions. | 1.17e-03 | 21 | 84 | 2 | 37014752 | |
| GeneFamily | Calcium voltage-gated channel subunits | 7.73e-05 | 26 | 58 | 3 | 253 | |
| GeneFamily | ATPase phospholipid transporting | 1.03e-03 | 15 | 58 | 2 | 1210 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | TNPO1 SLC4A7 MDN1 WASHC4 UTP25 PAPOLA MRPS17 TRAM1 SENP3 CD164 ZMYM2 TLR7 SNAPC3 SLC16A7 SLC9A6 | 5.64e-06 | 1215 | 83 | 15 | M41122 |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#2_top-relative-expression-ranked_100 | 3.50e-05 | 17 | 81 | 3 | gudmap_kidney_adult_RenCorpuscGlomer_k2_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | CACNA1D ADGRG3 WASHC4 MYO1D PAPOLA GRB10 UBR3 ATP8B1 SNAPC3 PHYHIPL FAM135A CDC23 | 3.55e-05 | 774 | 81 | 12 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ADGRG3 AP3S1 SLC4A7 MDN1 WDR75 GVINP1 STAC3 ZMYM2 UBR3 FYCO1 ACKR2 FAM135A PREX1 FMNL1 LEPR | 6.85e-05 | 1252 | 81 | 15 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| ToppCell | Dendritic_Cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.67e-06 | 191 | 84 | 6 | b51c8ff1279581088557bb36760c70209c77148c | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-06 | 193 | 84 | 6 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-06 | 197 | 84 | 6 | e0fc098bfb5a8b7824ae339f3adda30f78360d0b | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-06 | 197 | 84 | 6 | 363ae03310f63a586ba3cea2a59f35d5a335a54e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 197 | 84 | 6 | 57dafb3047745a44b2345b8036e159c3641d496e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-06 | 198 | 84 | 6 | 623f9d64c9e800d2d7f623392bf2f22b563f0249 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 84 | 6 | f19b729b03b5f225b9ed676f0ac31071a4354da3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.62e-06 | 150 | 84 | 5 | 6c39e73a0b05d4b26589f333ce13924e3d373b8d | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.06e-05 | 153 | 84 | 5 | e9567966fe4426176e2f2dc0be4832c769c9903a | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 161 | 84 | 5 | 5a8698790f9aba796dd2b64af419055c60bd7de8 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.40e-05 | 162 | 84 | 5 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.40e-05 | 162 | 84 | 5 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.40e-05 | 162 | 84 | 5 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-05 | 169 | 84 | 5 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-05 | 171 | 84 | 5 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | 5'-Adult-Distal_Rectal-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-05 | 173 | 84 | 5 | b335ca2a247156eba821943b2b9fc9922230b409 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 173 | 84 | 5 | 2415b6ff49f334da570577d4e93484d024a3dbd5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 173 | 84 | 5 | 2acd0693a2dfe04e3c1b2125ea63efe92d13150b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 175 | 84 | 5 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 175 | 84 | 5 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-05 | 175 | 84 | 5 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 176 | 84 | 5 | 238244294d08975df6bfa26b2b437db3654408ae | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-05 | 178 | 84 | 5 | 0b59e3d75b143bd7bf91a7800a49699c51e68c5a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-05 | 178 | 84 | 5 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 178 | 84 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-05 | 179 | 84 | 5 | dd3cf8fd10dc257d933a7f45860dc2e244c158b7 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 2.44e-05 | 182 | 84 | 5 | 8dd79fef8f8463ad3194f9cc07c6cacf2c886304 | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 2.51e-05 | 183 | 84 | 5 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 2.51e-05 | 183 | 84 | 5 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-T_&_ILC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.57e-05 | 184 | 84 | 5 | 51ae0963b4fb034c3f605ee4e5da513cba7aca35 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.57e-05 | 184 | 84 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-05 | 186 | 84 | 5 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-05 | 186 | 84 | 5 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.78e-05 | 187 | 84 | 5 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.08e-05 | 191 | 84 | 5 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 3.16e-05 | 192 | 84 | 5 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 192 | 84 | 5 | 86d792682ba51696f503c79625dd20f87bcf651f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 192 | 84 | 5 | d0ad6a205ad50a3c523fa68676996b289eabc5de | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 3.23e-05 | 193 | 84 | 5 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 193 | 84 | 5 | 3e3d7cb3e7242ec9c9677e07e303835649852b52 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 193 | 84 | 5 | f597fefc54327a1ad136e2f66b6e81cc5c761eb7 | |
| ToppCell | Dendritic_Cells|World / lung cells shred on cell class, cell subclass, sample id | 3.23e-05 | 193 | 84 | 5 | 7792eb6e247af2d7a8f80476f37dcd880922d625 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 194 | 84 | 5 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 195 | 84 | 5 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 3.40e-05 | 195 | 84 | 5 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 195 | 84 | 5 | 09df40ff9b493170861b3f6e57a942a834655b5c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 196 | 84 | 5 | 4370473693d2dd4a8c451a4c477eb79baa33ae12 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 3.48e-05 | 196 | 84 | 5 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-05 | 196 | 84 | 5 | 291c59b609985167c98a40d4e2caeea2fad74941 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 197 | 84 | 5 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 3.57e-05 | 197 | 84 | 5 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 197 | 84 | 5 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 197 | 84 | 5 | 826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 197 | 84 | 5 | 1eb9ff8467118b943b5d443cb996168e1e1206b5 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.65e-05 | 198 | 84 | 5 | 25b40926412a15ca91f30cd57a547a60396e9dd3 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 744b63fba33b176ab7dde11646ccb313665505f7 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 6ce7612ee2ae211eb0f73391e96089ad5431c537 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | ad7ae5106141669b353800fece833b3cd5bdccee | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | f3dc07a7cc8cf041da8fe610d21af595818cf2d8 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | 46f9c28b24e39acdf0481a02b6eb86ecdd83c504 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.91e-04 | 151 | 84 | 4 | 5906562efd36fbcb91f96e0a0d3a8fe999ba1e79 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 153 | 84 | 4 | 0307f10e772021ae68a42690634df458672a6df9 | |
| ToppCell | CV-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 2.06e-04 | 154 | 84 | 4 | 26bf81a86700db7e65c2384ffe94ed4253ea4047 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.16e-04 | 156 | 84 | 4 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | E16.5-samps-Myeloid|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.16e-04 | 156 | 84 | 4 | c7c73cef5700b0ae75280e62c94728434c712537 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.56e-04 | 163 | 84 | 4 | 961c3a1303108afd680365466045f3460a30a7b0 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 2.62e-04 | 164 | 84 | 4 | a07c6e13c07a90bc37db0915eb14931eb8309a1e | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.68e-04 | 165 | 84 | 4 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.68e-04 | 165 | 84 | 4 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.74e-04 | 166 | 84 | 4 | ceb0a48c0d853448fd45ac31dde046df9a178571 | |
| ToppCell | PND01-03-samps-Myeloid|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.74e-04 | 166 | 84 | 4 | 99dc8a186ec12d3563e81fa4618a814740332c73 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 168 | 84 | 4 | d7d19c93d1c3dd994e18e28d5f36ae7773ff5d7f | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 2.87e-04 | 168 | 84 | 4 | 8ade4d098aeecda2d80c1cad1cebe9a063eae948 | |
| ToppCell | Dendritic_Cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.87e-04 | 168 | 84 | 4 | 33618e5dbcee31f30afacacc9f6046782c100fb3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-04 | 169 | 84 | 4 | b2fdf9f842dc7c181bc951a8a6932c916ed835ef | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-04 | 169 | 84 | 4 | 2322f03a115c662f808ebfc892192b7d38d48181 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.07e-04 | 171 | 84 | 4 | c3e3ea09c73050372314a89b282e36ba5f339d73 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-04 | 172 | 84 | 4 | 72fbfa890995e47048b47199c170cc7dcd7661f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-04 | 172 | 84 | 4 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea | |
| ToppCell | CD8+_Memory_T_cell-FLU-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.14e-04 | 172 | 84 | 4 | 45ac433dbb3796f69e886c04457b2971403050ee | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-04 | 172 | 84 | 4 | 584af6537685cb459bf0fc298e6f46872016c116 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 174 | 84 | 4 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.28e-04 | 174 | 84 | 4 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-04 | 175 | 84 | 4 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-04 | 175 | 84 | 4 | f2c3e0f728a43d6988e793c8a50c964f7447db82 | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-04 | 176 | 84 | 4 | 3d372c1d527fcc118d1e5809f2524fc387682472 | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-04 | 176 | 84 | 4 | 7b3f3d9b33770edf294cee0eccaf8a46f9331461 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.42e-04 | 176 | 84 | 4 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-04 | 176 | 84 | 4 | 9c0fb2c6ae84febdf7c3d4e648985f597dcffe7a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-04 | 177 | 84 | 4 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 178 | 84 | 4 | 7467e5ab2fcb39cc4a2c7dd69722c91def3b6aea | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.65e-04 | 179 | 84 | 4 | abc6797bd3884aa75dca58fcb2523ee321243ab1 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.65e-04 | 179 | 84 | 4 | 0b996d6e881f31e6b80d359f7caac70ecdeb9982 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.80e-04 | 181 | 84 | 4 | a8d4b2340d99734bf9379b467fb481c598b9b4fb | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 181 | 84 | 4 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.80e-04 | 181 | 84 | 4 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.88e-04 | 182 | 84 | 4 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.88e-04 | 182 | 84 | 4 | 4a85429d365c4b2d73fc921f261b4b7635ac40bd | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.88e-04 | 182 | 84 | 4 | 53213af34af3337f5edc734d3b7b79e4349eac0d | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-04 | 182 | 84 | 4 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| Drug | Cinnarizine | 3.86e-06 | 9 | 83 | 3 | DB00568 | |
| Drug | Nimodipine | 3.86e-06 | 9 | 83 | 3 | DB00393 | |
| Drug | Mibefradil | 7.55e-06 | 11 | 83 | 3 | DB01388 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 7.37e-08 | 4 | 79 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Antibody Deficiency Syndrome | 1.22e-05 | 17 | 79 | 3 | C0003257 | |
| Disease | Immunologic Deficiency Syndromes | 3.15e-05 | 23 | 79 | 3 | C0021051 | |
| Disease | FEV change measurement, response to zileuton | 4.07e-05 | 25 | 79 | 3 | EFO_0005921, EFO_0007676 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.24e-04 | 36 | 79 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | hypertension | 1.78e-04 | 307 | 79 | 6 | EFO_0000537 | |
| Disease | Shortened QT interval | 3.83e-04 | 11 | 79 | 2 | C0151879 | |
| Disease | Manic Disorder | 9.26e-04 | 71 | 79 | 3 | C0024713 | |
| Disease | C-X-C motif chemokine 16 measurement | 1.05e-03 | 18 | 79 | 2 | EFO_0010911 | |
| Disease | pulse pressure measurement | CACNA1D ATP8B4 TRANK1 SLC4A7 ATG7 INPP5A SBF2 UBR3 ABCC9 QSOX2 PTCD3 | 1.17e-03 | 1392 | 79 | 11 | EFO_0005763 |
| Disease | Manic | 1.22e-03 | 78 | 79 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 1.26e-03 | 79 | 79 | 3 | C0005587 | |
| Disease | COVID-19, osteoarthritis | 1.30e-03 | 20 | 79 | 2 | MONDO_0005178, MONDO_0100096 | |
| Disease | alanine measurement | 1.61e-03 | 86 | 79 | 3 | EFO_0009765 | |
| Disease | autism spectrum disorder symptom | 1.73e-03 | 23 | 79 | 2 | EFO_0005426 | |
| Disease | Dyslipidemias | 1.88e-03 | 24 | 79 | 2 | C0242339 | |
| Disease | Anhedonia | 1.88e-03 | 24 | 79 | 2 | C0178417 | |
| Disease | Dyslipoproteinemias | 1.88e-03 | 24 | 79 | 2 | C0598784 | |
| Disease | Brugada Syndrome (disorder) | 1.88e-03 | 24 | 79 | 2 | C1142166 | |
| Disease | diet measurement | 1.94e-03 | 1049 | 79 | 9 | EFO_0008111 | |
| Disease | Endogenous Hyperinsulinism | 2.21e-03 | 26 | 79 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 2.21e-03 | 26 | 79 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 2.21e-03 | 26 | 79 | 2 | C1257965 | |
| Disease | mean arterial pressure | 2.23e-03 | 499 | 79 | 6 | EFO_0006340 | |
| Disease | Hyperinsulinism | 2.56e-03 | 28 | 79 | 2 | C0020459 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LYAFSSHRFRQYLKA | 311 | O00590 | |
| YRFFDHQSKLSFKYD | 81 | Q96KX2 | |
| TAFRYLAQYYFKCKL | 511 | Q9UJX2 | |
| FRKPYNFLKYHFEAL | 206 | P07357 | |
| YLHNSKSFFRSYIKN | 2146 | Q7Z2Y8 | |
| KSFFRSYIKNHIKRY | 2151 | Q7Z2Y8 | |
| YAFIGQKFRNYFLKI | 316 | P51684 | |
| FVLSLVKKHYRLQFY | 181 | O95674 | |
| KNSFFNYRKKLASYF | 431 | Q96DT5 | |
| FNTYFGHYFLKLSLV | 371 | Q86Y34 | |
| FYFIQKYFRVASKDL | 1146 | O60706 | |
| KFLCYFFYKNFAFTL | 871 | Q8TF62 | |
| NKLIYRHYATLYFVF | 61 | Q92572 | |
| LRYFFYKNFAFTLVH | 951 | O43520 | |
| IHFYPTFRYFKAFTK | 136 | Q6ZRP7 | |
| YKRTHAAYNLLFFAS | 261 | Q969V3 | |
| YVFFVNTLFHAYKRE | 766 | P0C881 | |
| YVFFVNTLFHAYKRE | 766 | B2RC85 | |
| GKFYATFLIQDYFRK | 1581 | O60840 | |
| DQHRNFYYSKFFDLI | 451 | Q96EY7 | |
| LYHYYKQFFDRVQAK | 3916 | Q9NU22 | |
| FNYFFYNKRLKRIVF | 186 | Q9H063 | |
| KDNQDIYKRFLFHYS | 61 | Q5H8A3 | |
| FFLYKFCKSKERNYH | 181 | Q04900 | |
| YLKFLAFHYVSNRFK | 1496 | Q86WG5 | |
| SLHKFSYKLEYLLQF | 41 | Q9BQS8 | |
| RFKYYLNKLHTFLSL | 1341 | Q9P2D6 | |
| TFHFLYFKDKIFNVA | 381 | Q9UK99 | |
| SFYFLHESLKNIYQF | 106 | Q14642 | |
| HKLYVLLFAKFFFLI | 316 | Q96R28 | |
| YLDFSLFKHRGFLIY | 236 | O60669 | |
| IKNRKFHFPFYYLLA | 56 | Q9UBY5 | |
| SLFKNLFRNYNYKVH | 146 | P48357 | |
| IHKFKYAFYLSCREL | 236 | Q9NX02 | |
| TGFKFLFTLFRKYYL | 236 | Q2PPJ7 | |
| NFFQKYKHYIVLLAS | 366 | P51003 | |
| FFQKYRHYIVLTASA | 366 | Q9BWT3 | |
| VVNTYFRHFKLYKYV | 201 | A1A4V9 | |
| YKFDDNYAFLHRTLK | 171 | Q8IUX4 | |
| YPHIFYFHFKNLRKA | 196 | Q8IUX4 | |
| YFHFKNLRKAYGRNE | 201 | Q8IUX4 | |
| FLLLTFADLKKYHFY | 131 | O95352 | |
| FYATFLIQEYFRKFK | 1666 | Q13936 | |
| IYNASLKKYFLITFF | 201 | P35575 | |
| FLKFFTYLHRLSCYQ | 171 | Q9Y5Q5 | |
| FFSLFSRFIKAYKKA | 986 | O95466 | |
| SKFLFRKNYAKYEFF | 241 | Q13322 | |
| KDYVFKLQFKSHVYF | 991 | O94887 | |
| AYFYGFFKNKRIVLF | 266 | O75844 | |
| FYATFLIQDYFRKFK | 1606 | Q01668 | |
| HRLRKFYKPFNLMFY | 426 | Q9Y661 | |
| KRFEKVYTHNLYYLA | 201 | Q96EK5 | |
| ISFGSLLYKYAFKFF | 451 | Q9BXW9 | |
| YFAKRFKRKNYHHSL | 651 | Q6UXK5 | |
| AAYFFYKKRRVHLPQ | 1406 | P22897 | |
| LLRKYSFHKNIVSFY | 96 | Q7Z2Y5 | |
| LKFSVFYRNQHKEYF | 181 | Q96FC7 | |
| LFTERFHFYKRYTIK | 666 | Q68CQ4 | |
| FHFYKRYTIKGIRNL | 671 | Q68CQ4 | |
| FFLSSFLKQFKTKRY | 836 | Q9Y6M7 | |
| FYAGYSLKRRHFFRN | 161 | Q92581 | |
| VFTYFFKRTQYFRKN | 266 | Q6P4A7 | |
| YVHFLLNYRNKFKEQ | 16 | Q8WW32 | |
| ALKVIFYLDSYHFSK | 1436 | Q8TCU6 | |
| KYFNKRKTYFAHDAL | 41 | Q9Y2R5 | |
| KFYLTYPTKRNEFHF | 231 | Q9BQ13 | |
| HISKDLYKSAFFYFE | 241 | Q92966 | |
| LFESFKSYKGLFYFL | 701 | P53675 | |
| KVHFFNSFFYDKLRT | 421 | Q9H4L4 | |
| HLFALSTLYFYKFFL | 126 | Q5JXX7 | |
| FLAFQTSRYKLHYYE | 61 | Q9Y5R8 | |
| FSFLLSIFRSKYHGY | 326 | Q13454 | |
| TFKSYYLRNTFHKAL | 341 | Q96MW7 | |
| AAVREFYLSVYFFKK | 171 | Q8IWA0 | |
| KYLYNFFLKDNSHVI | 576 | Q8TEA7 | |
| YAKTENFKIAFYLSH | 961 | Q9NYK1 | |
| FAFSKYQHKNLLILY | 536 | Q92973 | |
| LNTLFYFNTKYFGLK | 1216 | Q9UBW7 | |
| AFYRFSYLTKHKIIH | 381 | Q9H8G1 | |
| FLFHISRLFYFSNEK | 231 | Q15629 | |
| YKVAFTKTFVQHYAF | 411 | Q6ZT12 | |
| FTYQFLKKKFYIFSQ | 841 | Q2M389 | |
| FRFYRFALKEYIHFL | 2256 | O15050 | |
| FQQSHYFVALYRFKA | 246 | Q96MF2 | |
| ISFKTYFSGNYFRHI | 191 | Q7L8A9 | |
| KVAYFYCLSNNKHFL | 321 | Q68DK2 | |
| FAFRQTYEKFLHRYK | 626 | O94832 | |
| YGFQFKAFHFYLTRA | 131 | Q13508 |